Stage | MiRNAs | Cell expression and mechanism | Reference |
---|---|---|---|
Development | MiR-125b | MiR-125b is involved in hematopoietic stem cell survival in lymphoid balance | Ooi et al.21 |
MiR-181a | MiR-181a enhances DP cell antigen sensitivity, and inhibits Bcl-2, CD69 expression, and TCR effects the positive clone selection of T cells | Wu et al.8 | |
Liu et al.22 | |||
Li et al.25 | |||
MiR-150 | During T cell maturation process, upregulation miR-150 inhibits the expression of the target gene NOTCH3 | Ghisi et al.27 | |
Activation Proliferation Apoptosis | MiR-214 | After stimulation, highly expressed miR-214 inhibited target gene PTEN expression in the proliferation of T cells | Jindra et al.18 |
MiR-130/301 | During CD8+T cell activation, miR-130 and MiR-301 are upregulated, inhibit of CD69 expression | Zhang et al.28 | |
MiR-155 MiR-221 | High expressions of miR-155 and miR-221 inhibited the expression of PIK3R1 in CD4+T cells | Grigoryev et al.29 | |
MiR-182 | MiR-182 binds to 3′-UTR of mRNA of Foxo1 in T helper cells | Stittrich et al.30 | |
MiR-21 | MiR-21 regulates the survival of activated memory T cell and induces CCR-7 expression in activated naive T cells | Smigielska-Czepiel et al.31 | |
MiR-17∼92 | In Th1 cells, miR-19 and miR17 target PTEN and CREB1, respectively, are involved in Th1 cell immune response. MiR-17∼92 gene cluster exhibits reduced expression and inhibits Bim and PTEN expressions, which affect apoptosis | Jiang et al.33 | |
Xiao et al.36 | |||
MiR-150 | MiR-150 and miR-139 regulate perforin, eomesodermin, and IL-2Rα expressions in differentiation CTL cell, involved in inflammation and antigen stimulation | Trifari et al.37 | |
MiR-139 | |||
MiR-15a/16-1 | MiR-15a/16-1 is downregulated, the upregulated target gene Bcl-2 affects the progression of apoptosis in CD4+T cells | Lorenzi et al.38 | |
MiR-17∼92 | MiR-17∼92 gene cluster inhibits Bim expression, which facilitates glucocorticoid-induced apoptosis in CD4+T cells | Molitoris et al.40 | |
MiR-122 | In apoptosis CTCL cells, miR-122 is upregulated, which activates Akt-related pathway; indicated that miR-122 amplifies the Akt/p53 anti-apoptosis pathway | Manfè et al.41 | |
The development of functional peripheral T cell subset | MiR-150 | In IL-15/IL-2-induced CD8 T cells, the target gene of miR-150 is KChiP1, which affects cell phenotype and self-renewal capacity via a negative feedback pathway | Almanza et al.42 |
MiR-142-5p | MiR-142-5p associated with CD4+CD25+ T cell proliferation by binding to the 3′-UTR of mRNA of GARP | Zhou et al.43 | |
MiR-29 | MiR-29 regulates T-box transcription factors and IFN-γ production in Th cells | Ma et al.45 Steiner et al.46 | |
MiR-125p | MiR-125p terminates the differentiation from naïve T cells to effector cells | Rossi et al.48 | |
MiR-24 MiR-210 MiR-145 | MiR-24, miR-210, miR-95, and miR-145 are upregulated, miR-24 and miR-210 miR-95 regulate FOXP3 expression miR-145 negatively regulates the CTLA-4 expression in Treg cells | Fayyad-Kazan et al.49 | |
MiR-10a | MiR-10a restricted Treg cell differentiation into Th17 cells | Takahashi et al.50 | |
MiR-155 | MiR-155 is upregulated, FOXOa3, the target gene of miR-155, negatively affect the Akt signaling pathway in stimulated Treg cells | Yamamoto et al.51 | |
MiR-146 | MiR-146 inhibits STAT1 expression by controlling Th1 response via Treg cell-mediated regulation | Lu et al.52 | |
Cancer immunity | MiR-222 MiR-339 | Dicer-regulated miR-222 and miR-339 promote resistance of cancer cells to cytotoxic T-lymphocytes by downregulating of ICAM-1 | Ueda et al.54 |
MiR-513 | Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating miR-513 | Gong et al.55 | |
MiR-29 | MiR-29 modulates the expression of the immunoinhibitory molecule B7-H3 | Xu et al.56 | |
MiR-122 | MiR-122 binds the IL-1α 3’-untranslated region | Gao et al.57 |